Company intelligence / Profile preview

Restech

San Diego, California, USArestech.net ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Restech is known for its pH monitoring technology, particularly the Dx-pH Measurement System, which is FDA-cleared and commercially available. The system provides real-time measurement and recording of pH levels in the oropharynx to aid diagnosis and management of laryngopharyngeal reflux. Clinical studies have demonstrated its utility in detecting acid exposure above the upper esophageal sphincter.

Therapeutic areas: Gastroenterology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Collaborations with clinical research centers and ENT specialists

Beyond the preview

Go deeper on Restech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Restech.

Explore the full profile